Ka Lee Pharmaceuticals - B (01672) plans to discount approximately 9.9% of the additional shares, raising a net amount of HK$4.68 billion.

Capital Financial APP News, Geri Pharmaceutical-B (01672) announced that on August 19, 2025, the company, the selling party (JJW12 Limited) and the placement agent entered into a placement and subscription agreement. (i) The selling party agreed to sell, and the placement agent agreed to act as the selling party agent, to facilitate the placement to the subscribers (professional, institutional, corporate or other investors) at a price of HK$16.45 per share to purchase 52.4 million shares held by the selling party, and (ii) the selling party conditionally agreed to subscribe, and the company conditionally agreed to issue 28.82 million new shares at the placement price. It is expected that no subscriber will become a major shareholder of the company after the completion of the placement and subscription. The directors have made all reasonable inquiries and are deeply aware, fully informed and convinced that the subscribers and their respective ultimate beneficial owners are independent third parties.